Enliven Therapeutics, Inc. (ELVN)
NASDAQ: ELVN · Real-Time Price · USD
17.05
-0.14 (-0.81%)
Apr 15, 2025, 4:00 PM EDT - Market closed
Enliven Therapeutics Market Cap
Enliven Therapeutics has a market cap or net worth of $835.53 million as of April 15, 2025. Its market cap has increased by 6.92% in one year.
Market Cap
835.53M
Enterprise Value
522.09M
1-Year Change
6.92%
Ranking
Category
Stock Price
$17.05
Market Cap Chart
Since February 24, 2023, Enliven Therapeutics's market cap has decreased from $974.02M to $835.53M, a decrease of -14.22%. That is a compound annual growth rate of -6.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 15, 2025 | 835.53M | -24.00% |
| Dec 31, 2024 | 1.10B | 92.74% |
| Dec 29, 2023 | 570.37M | -41.44% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 677.40B |
| UnitedHealth Group | 536.99B |
| Johnson & Johnson | 371.98B |
| AbbVie | 316.82B |
| Novo Nordisk | 294.67B |
| Abbott Laboratories | 221.92B |
| AstraZeneca | 210.97B |
| Novartis AG | 206.74B |